Anika Therapeutics, Inc. insider trading

ANIKNASDAQ

$19.10-0.26 (-1.34% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+109.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

CRCheryl R. BlanchardDirector2.0215%of company
DCDavid ColleranEVP, General Counsel, Corp Sec0.5049%of company
JBJohn B. Henneman IIIDirector0.4877%of company
SRStephen RichardDirector0.4354%of company
GPGary P. FischettiDirector0.4036%of company
SLSheryl L. ConleyDirector0.3958%of company
GRGlenn R. LarsenDirector0.3755%of company
SLSusan L. N. VogtDirector0.3752%of company
SDStephen D. GriffinPresident and CEO0.3435%of company
JHJoseph H. CapperDirector0.2302%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
ANIK	Gary P. FischettiDirector	Open market purchase$20.3K	+1.9%	$20.32	$20.3K	Aug 4, 2026	Aug 5, 2026
ANIK	Gary P. FischettiDirector	Open market purchase$20.7K	+1.9%	$20.75	$20.7K	Aug 3, 2026	Aug 5, 2026
ANIK	John B. Henneman IIIDirector	Open market purchase$73.3K	+10.0%	$14.66	$73.3K	May 1, 2026	May 4, 2026
ANIK	Stephen D. GriffinPresident and CEO	Open market purchase$150K	+50.9%	$12.29	$150K	Apr 30, 2026	Apr 30, 2026

End of history · 4 transactions